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Connective Tissue Activation 
II. Abnormalities of Cultured Rheumatoid Synovial Cells 
C. Wil l iam Castor 
With the technical assistance of 
Susan F. Smith, James C. Ritchie and Emily L. Dorstewitz 
Rheumatoid synovial cells grown in vitro demonstrated: a) increased rate of 
lactate formation, b) increased rate of glucose uptake, c) increased rate of 
hyaluronate synthesis, d) decreased sensitivity to exogenous activator and e) in- 
creased concentrations of an endogenous activator. Exogenous activator was 
shown to be capable of inducing cortisol unresponsiveness i n  relation to sup- 
pression of hyaluronate synthesis. Evidence that exogenous activator i s  not long 
retained by synovial cells suggests that elevated levels in rheumatoid cells are 
due to accentuated endogenous formation. Elevated activator peptide content of 
rheumatoid synovial cells provides an explanation for many of the differences 
between normal and rheumatoid synovial cells in vitro. 
Rheumatoid arthritis is a disease of man 
characterized by chronic joint effusions 
containing excessive quantities of hy- 
aluronic acid of inferior molecular weight 
(1). and by destructive, proliferative syno- 
vial pannus which exhibits accelerated en- 
ergy metabolism. Accelerated energy metab- 
olism of rheumatoid synovial tissue was 
documented by tissue slice studies which 
revealed increased glucose and oxygen con- 
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sumption and increased lactate formation 
(Z), and by in vivo studies in rheumatoid 
joints where severe joint disease was associ- 
ated with a fall in joint fluid pOz and a rise 
in lactate (3). 
While i t  is reasonably certain that the 
abnormal biochemical behavior of the rheu- 
matoid synovial membrane may be partial- 
ly explained by ithe deviant behavior of 
synovial intimal (lining) cells themselves, 
it is by no means clear that a primary 
defect lies in the rheumatoid synovial inti- 
ma1 cells. I t  is possible that rheumatoid 
synovial intimal cells may actually be inno- 
cent bystanders, being forced into abnor- 
mal functional patterns by continuing ex- 
tracellular influences. In  the context of this 
question, our earlier reports (4, 5), which 
first identified quantifiable abnormalities 
in rheumatoid synovial cells propagated in 
tissue culture, provide a framework for 
examining the alternative possibilities. 
These studies showed that rheumatoid syn- 
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ovial cells, cultivated in vitro, produced 
underpolymerized h yaluronic acid, ex- 
hibited an abnormally slow growth rate, 
and were hyporesponsive to the suppressive 
regulatory effects of hydrocortisone. The 
defective response to cortisol shown by rheu- 
matoid cells was manifested by failure to 
exhibit depressed formation of extracellu- 
lar products, such as hyaluronic acid and 
collagen, to the same degree as normal 
synovial cultures exposed to this hormone. 
It is noteworthy that these abnormalities 
were demonstrated in cells which were 
propagated for months in vitro, suggesting 
that the cause of the abnormalities was 
either a persistent nonviable entity, or pos- 
sibly a replicating infectious agent. It is 
difficult to be certain that rheumatoid syno- 
vial cells do not carry ever-diminishing 
amounts of a potent trace substance ade- 
quate to induce the abnormalities visual- 
ized in culture, a trace substance which 
may have been contributed to the progeni- 
tor rheumatoid synovial cells by an exter- 
nal agency. 
The demonstration of a connective tissue 
activating peptide (CTAP), found in most 
cells, and shown to be capable of stimulat- 
ing hyaluronic acid and energy metabolism 
in synovial cells, provides a possible expla- 
nation for the self-perpetuating nature of 
chronic rheumatoid inflammation (6-8). I t  
was clear from our earlier studies that 
CTAP is present in both lymphocytes and 
plymorphonuclear leukocytes as well as in 
cultivated synovial cells of both normal 
and rheumatoid origin. In a recent commu- 
nication, we suggested that the activator 
substance (CTAP) induced normal synovi- 
a1 cells to exhibit behavior characteristic of 
rheumatoid cells in the culture environ- 
ment, and provided preliminary evidence 
indicating that retention of increased 
amounts of CTAP activity was responsible 
for many of the abnormalities characteris- 
tic of rheumatoid cells (9). 
The present report demonstrates other 
metabolic abnormalities in rheumatoid 
fibroblasts, shows that such cultures have 
excessive quantities of CTAP, and finally, 
provides experimental evidence indicating 
that increased endogenous formation of 
CTAP, rather than prolonged storage, is 
the likely explanation for the high level of 
activator found in rheumatoid cells. 
MATERIALS AND METHODS 
Synovial membrane for tissue culture studies was 
obtained at the time of arthrotomy or amputatian. 
A portion of the tissue was divided hto small 
fragments and used to generate cell cultures usbg 
techniques reported in detail earlier (4,10,11) , and 
another portion was processed for histologic exami 
nation. The routine media used in growing cell 
cultures consisted of 80% medium 1066 with 10% 
fetal calf serum and 10% heat inactivated human 
serum, supplemented with L-glutamine, penicillin 
an1 streptomycin. Cells were enumerated and sized 
electronically with a Coulter Model B cell counter.. 
Protein was measured by the method of Oyama and 
Eagle (12), and glucose was estimated with a 
glucose oxidase method (13). Lactate was meas- 
ured by the Barker-Summerson method (14) and 
pyruvate by an enzymatic procedure (15). Hy- 
aluronic acid from serum-containing tissue culture 
media was measured by a method reported earlier 
from this laboratory, involving isolation of the 
polymer (16) and measurement of the uronic acid 
moiety by a modified carbazole procedure (17). In 
the assay procedure for CTAP, which was carried 
out in the absence of serum, hyaluronate was 
isolated using cetylpyridininm chloride (8) and the 
uronic acid measured by the carbazole procedure 
(17) . The bioassay procedure for measuring CTAP 
consists essentially of measuring the capacity of a 
standard normal synovial cell culture to show 
stimulation of hyaluronic acid synthesis in the 
presence of an activating substance. The material to 
be tested for CTfAP activity is added to 2.0 ml of 
serum-free Eagle’s synthetic media and incubated 
with 1 million normal synovial fibroblasts for 40 
hours. At this time the culture is sacrificed, the 
total culture protein is measured and the total 
culture hyaluronic acid measured (8). The units of 
f Coulter Electronics, Hialeah, Florida. 
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CT.4P activity may then be estimated from the 
following relation: 
CTAP (units/ml) = A2-A1 
10 x v 
where A, = hyaluronic acid synthesis rate in the 
stimulated culture corrected to p g  HA/mg cell 
protein/24 hr, and A, is this measure in the control 
flasks. V = the volume of activator material added 
to the standard test system in milliliters. Statistical 
comparison of mean values in control and experi- 
mental populations was carried out using the 
Student-Fisher t procedure. 
RESULTS 
Data from characterizationt studies. 
Data collected from routine characteriza- 
tion studies carried out during the past 
three years with nonrheumatoid and rheu- 
matoid cell strains is displayed in Table 1. 
In such studies, 1 million synovial fibro- 
blasts are inoculated into a serum dilution 
bottle nourished by 10 ml of standard 
serum-containing medium. The medium is 
changed totally at two days and five days 
with the culture terminated on the seventh 
day. The cells are dispersed with trypsin, 
counted and sized with an electronic cell 
counter and the media utilized for chemi- 
cal analysis. The measurements of hy- 
aluronic acid synthesis rate, glucose uptake 
rate, and lactate output rate are based on 
the chemical analyses made on the final 
medium change and the final cell count in 
the culture flasks. The mean rates of hy- 
aluronic acid synthesis, glucose uptake and 
lactate- formation were considerably in- 
creased in the rheumatoid. synovial strains, 
both hyaluronic acid and lactate measure- 
ments being statistically significantly differ- 
sent than the controls, and the glucose u p  
take measurements approaching significant 
levels. These data from a group of unselect- 
-f"Characterization" studies denote a standardized 
.set of measurements made on all newly generated 
.cell strains to assess growth rate, HA synthesis rate, 
.HA polymer size. response to cortisol, etc. 
ed cultures would suggest that the rheuma- 
toid cultures exhibit the characteristics of 
activation which we have demonstrated can 
be induced in normal cell strains (6-8). 
Responsiveness to exogenous activa- 
tor. It soon became obvious that rheu- 
matoid cell strains not only behaved as if 
they were already partially activated but 
that they responded rather sluggishly when 
exposed to exogenous CTAP. Table 2 
provides a comparison of the basal per- 
formance of a group OE rheumatoid and 
nonrheumatoid cell cultures examined un- 
der the conditions established for the 
CTAP bioassay. In  the- absence of ex- 
ogenous activator (basal conditions), the 
rheumatoid strains produced approximate- 
ly twice as much hyaluronic acid per unit 
cell of protein per unit time as the nonrheu- 
matoid cultures. When similar amounts of 
an activator (CTAP) derived from rheu- 
matoid cells was added to the nonrheuma- 
toid cultures, the HA synthesis rate was 
markedly stimulated while rheumatoid 
cells under the same circumstances showed 
only a modest response. The muted re- 
sponse to exogenous activator on the part 
of rheumatoid cells is shown schematically 
in Fig 1 where two rheumatoid fibroblast 
strains are compared with a strain from 
normal synovium. It  is clear that both of 
the rheumatoid synovial strains show basal 
levels somewhat higher than the normal 
culture, but in one case there is virtually 
no increase in hyaluronate synthesis with 
increasing amounts of activator, and in the 
case of DW, the increase is of modest 
proportions. In  other experiments we have 
shown that adding hyaluronate to the assay 
cultures, (thus increasing the basal HA 
level) does not prevent the effects of ex- 
ogenous activator. 
Activator content of synovlal cell 
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Table 1. Evidence for Residual Activation in Some Rheumatoid Synovial Strains 
HA Glucose Lactate 
synthesis uptake output 
rate Gkg/ GM/lOB (pM/lOs 
Patient Sex Age Diagnosis ce11/24 hr) cells/24 hr) cells/24 hr) 
BS F 46 DJ D 6.3 0.39 - 
KP M 18 Rheumatoid 9.9 1.78 - 
Spondylitis 
Ca W M 75 Normal 11.2 1.86 2.62 
FS M 81 Normal 12.4 1.73 3.37 
RN M 26 TA 14.4 1.17 2.33 
TH M 15 ? TA 14.5 2.04 1.62 
HH F 29 Normal 15.3 1.69 2.66 
Wa K M 71 Normal 17.7 1.24 2.66 
FC M 54 DJ D 17.9 2.80 2.60 
DM F 13 Normal 23.3 0.99 - 
cv F 91 Normal 35.3 2.72 - 

















































17 17 10 
2.280 2.035 4.658 
P<0.05 P <0.10 P <0.01 
* DJD = degenerative joint disease; TA = traumatic arthritis; RA = rheumatoid arthritis. 
t The nonrheumatoid and rheumatoid groups are compared for each parameter in terms of the mean 
f the standard error of the mean. The significance of differences between means was evaluated by the 
Student-Fisher t method. 
strains. In view of the fact that rheuma- 
toid synovial cells frequently behaved as if 
they were activated and showed a dimin- 
ished capacity to respond to exogenous 
“activator,” whether of synovial, splenic, or 
HEp-2 cell origin, i t  seemed possible that 
these cells contained excessive amounts of 
an endogenous activator. To seek direct 
confirmation of this possibility we prepared 
saline extracts of four cell strains after 
disruption by freeze-thawing. The nonrheu- 
matoid cell strains and two rheumatoid 
cell strains were subjected to the extraction 
procedure, the extracts dialyzed against 
water, clarified by centrifugation, and ster- 
ilized by filtration through millipore filters. 
The crude sterile extracts were placed on 
normal synovial cultures and the resulting 
data is recorded in Table 3. It was clear 
from this preliminary experiment that ex- 
tracts from the two rheumatoid cell strains 
were more potent than the extracts of cell 
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Fig 1. The activator (CTAP) added was derived from 
rheumatoid cell strain DW. 10 11 of the activator extract 
represents lo" DW cells. 
Table 2. Comparative Activation of 





b g  HA/ Statistical 
mg cell Nonrheu- Rheu- parameters 
protein/ matoid matoid 
24 hr) (30)t (12) N t P  
Basal 1 3 . 8 f  1 .9  2 7 . 0 f  3.8 40 3.451 0.01 
Activated 6 5 . 5 i  4.6 44.6& 4 .8  40 2.718 0.01 
Activated/Basal 
Ratio, 6 . 9 f 0 . 8  1 . 9 f  0.2 40 4.051 0.01 
(HA) 
*The experiments summarized in this table 
were carried out with 1.0 X 106 synovial cells 
per T-15 flask (or 2.0 X 1O6/T-3O flask), in the ab- 
sence of serum. Data are presented as means 
f standard errors of the means. 
t Numbers in parentheses indicate the number 
of measurements. Nonrheumatoid strains used 
were Caw, WaK, and RN. Rheumatoid cell strains 
included: OD, DW, GR, and JJ. 
strains from patients with osteoarthritis or 
traumat'ic arthritis. This preliminary assess- 
ment of the increased CTAP content of 
rheumatoid cell strains led us subsequently 
to make quantitative measurements of this 
material in a larger series of nonrheuma- 
toid and rheumatoid cell strains. Extracts 
of cells were prepared by freeze-thawing 
with a phosphate saline buffer containing 
0.1% p-mercaptoethanol, followed by cen- 
trifugation and then dialysis and filtration 
of the supernatant fluid. Both the nonrheu- 
matoid and the rheumatoid cell extracts 
were assayed simultaneously on two occa- 
sions, once against normal cell strain HH 
and a second time against nonrheumatoid 
strain T H .  In each bioassay, the rheuma- 
toid cell strains had about four times as 
much CTAP activity as the normal cell 
strains, as can be seen from Table 4. Table 
4 also provides an opportunity to see the 
sort of variation that may occur when a 
particular activator preparation is assayed 
against different cell strains. It is for this 
reason that we have advocated that quanti- 
tative comparisons be carried out by simul- 
taneous assay of different preparations 
against the same indicator cell strain. 
Chronic activation of normal synovial 
connective tissue cells. In order to de- 
termine whether or not repetitive exposure 
of a normal cell strain to exogenous activa- 
tor would induce permanent behavioral 
changes, we undertook a seven-week exper- 
iment with normal cell strain HH wherein 
three cultures received phosphate buffer 
and three received a potent activator (par- 
tially purified by gel filtration) derived 
from the HEp2 cell strain. The activator 
(11.5 ,,g protein) or vehicle (0.2 ml) was 
added at the time of the initial inoculation 
of 1 million cells into the culture vessels 
and at each medium change. On D.;y 7 the 
cultures were trypsinized, the cells counted, 
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Traumatic arthritis (MB) 
Rheumatoid arthritis (DW) 
Rheumatoid arthritis (EF) 
HA increment/ 
flask/lO8 cell 
Amount of extract added Hyaluronate/flask equivalentsof extract 
(cell equivalent) be) be) 
0 213 0 
3.2 X l o 6  384 54 
3.6 X 1 0 6  489 77 
2.6 X lo6  a12 230 
5.5 x 106 925 130 
* Normal WaK synovial cells served as the indicator strain in this experiment, carried out during the 
final 3 days of a 7-day growth cycle in serum dilution bottles nourished by our standard serum-con- 
taining media. Similar numbers of normal WaK synovial cells were in the various flasks during the 
experiment, and duplicate flasks were in each group. 


































CTAP (units/107 cells) 
Measured with Measured with 















Mean 4.3 f 1.5 2.3 f 0.9 ’ 18.7 f 2.6 10.5 f 1.7 
Statistical information N 12 11 
t 4.861 4.411 
P < 0.01 < 0.01 
sized, and the media stored for chemical 
analysis. Three million cells from the ac- 
tivated cultures were used to inoculate 
three new daughter subcultures and the 
control flasks were subcultured in the same 
manner. The excess cells from both the 
control and activated cultures not used for 
subcultures were frozen for subsequent ex- 
amination. This process was repeated at 
weekly intervals for seven weeks. At the 
end of the fifth week a third group of 
cultures was established, consisting of cells 
which had been exposed to continuous 
activati.on for five weeks, but to which no 
further “activator”- material was added. 
This third group was the “omit activator” 
group. 
As shown in Fig 2, the hyaluronic acid 
synthesis rate of the nonactivated cultures 
remained essentially constant over the peri- 
od of observation, while those cultures re- 
ceiving activator substance as a medium 
component exhibited a hyaluronic acid 
synthesis rate approximately double that of 
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Time in Weeks 
Fig 2. Hyaluronate synthesis remained elevated in the 
presence of exogenous activator, but returned to control 
levels by three weeks after discontinuation of this additive. 
the control flasks. The hyaluronic acid syn- 
thesis rate of cultures that had been contin- 
uously activated for five weeks, and from 
which the activator was withdrawn, ex- 
hibited a prompt fall in hyaluronic acid 
synthesis rate. The effects of activation on 
the hyaluronic acid synthesis rate could no 
longer be distinguished three weeks after 
withdrawal of the peptide material. Fig 3 
presents the details of the effect of chronic 
activation on several parameters of carbo- 
hydrate metabolism. It is clear from Fig 3 
that with repetitive addition of activator 
substance to the cultures, increased glucose 
uptake, increased elaboration of lactate 
and maintenance of a very high lactate to 
pyruvate ratio was observed, AF long as 
exogenous activator WAF added to the cul- 
tures. -411 of the parameters of carbohy- 
drate metabolism returned rapidly to the 
control levels when the activator substance 
was omitted, as indicated in Fig 3. Meas- 
ures of cellular energy metabolism seemed 
to return to control values after omission oE 
CTAP somewhat faster than did the rate of 
hyaluronic acid synthesis. The  effect of 
chronic activation on the proliferative ca- 
pacity of normal synovial cells- appears 
complex, and may involve dominance of 
@e activation process over factors control- 
ling "strain aging." I t  is clear from Fig 4 
that culture growth was similar in control 
and activated cultures during the first three 
weeks, and then control cultures showed a 
decreased growth rate (a function of strain 
aging) which we have noted previously 
(18). Activated cultures did not show the 
same degree of slowing of the growth rate. 
and in a sense, the activator may be regard- 
ed as responsible for increased prolifer- 
ation relative to their age matched (in 
vitro age) controls. 
Activator content of synovial ceiis 
during chronic activation. Counted ali- 
quots of cells were extracted with saline 
buffer (pH 7.0) containing p-mercapto- 
ethanol (0.1%) after repetitive freeze- 
thawing and were processed as indicated 
above to be assayed for their CTAP con- 
tent. Fig 5 illustrates the relative CTAP 
concentration in cells from control and 
activated cultures during the time course of 
the chronic.. activation experiment. The 
HH control cultures maintained a relative- 
ly constant level of CTAP in the range of 
six to seven units per l o 7  cells while the 
cultures receiving activator at each medi- 
um change very rapidly manifested ex- 
tremely high levels of CTAP activity. I t  
was interesting to note that the very high 
IeveIs of CTAP activity did not occur until 
the end of the second week of activation. 
Perhaps the most important point to be 
extracted from this experiment is that in 
those cultures from which the activator was 
omitted, there was a prompt fall in the 
cellular level of CTAP activity back to 
control levels. We take this experiment to 
suggest that normal synovial fibroblasts are 
not permanently altered by repetitive ex- 
posure to an exogenous activator and that 
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their abnormal biochemical behavior and relative unresponsiveness to glucocorti- 
elevated content of activator return rela- coids. It is clear from Table 5 that both 
tively rapidly to normal when the external activator and lactate effectively oppose that 
source of stimulation is removed. action of cortisol, which depresses hy- 
aluronate formation, unlike the situation 




u dntro l  
8 4  Cultures 
0 
2t - 
1 2 3 4 5 6 7 8  
Time i n  Weeks 
Fig 4. Chronic activation appears to impede the 
diminishing growth rate that accompanies strain aging. 
Fig 3. Glucose uptake and lactate 
formation were greatly stimulated by 
activator, but rapidly returned to 
normal levels on omission of the 
polypeptide. The markedly elevated 
1actate:pyruvate ratio reflects mod- 
erate depression of medium pyruvate 
as well as elevated lactate. 
loor j h c t i v a t e d '  Cultures 
Control 
20 Cultures 
0 1 2 3 4 5 6  
Time in Weeks 
Fig 5. High levels of activator are recovered from cells 
receiving exogenous activator, but only during the period 
when it was being administered to the cultures. 
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nonrheumatoid strains, stimulated by ac- 
tivator were not depressed to the level 
induced by cortisol alone. While it is obvi- 
ous that cortisol has a major suppressive 
effect on activator-induced hyperproduc- 
tion of hyaluronate, (two right hand 
columns) as we reported earlier (20), it is 
clear that populations of activated cells 
would be hyporesponsive to cortisol s u p  
pression when compared to nonactivated 
cell populations. Since activation increases 
lactate in the cellular environment, we 
have been interested in the possibility that 
this metabolic alteration was involved in 
Table 5. Activation and Relative 
Unresponsiveness to Glucocorticoid* 
Hyaluronate synthesis 
b d c e l  I/day) 
Acti- 
vator 
N o + + +  
addi- Cor- Acti- cor- 
tive tisol vator tisol 
NonRA strain (RN) 
NonRA strain 
RA strain (DW) 
(Caw) 
NonRA strain 
NonRA strain (RN) 
(WaK) 
11.1 6.1 34.4 12.8 
10.0 7.2 57.6 24.7 
59.5 38.5 89.4 51.4 
Lac- 
tate 
N o + + +  
Add- Cor- Lac- Cor- 
tive tisol tate tisol 
18.8 9.8 28.5 21.5 
11.1 6.1 13.9t 7.7 
* These experiments were carried out in serum 
dilution bottles, inoculated with 108 cells, nour- 
ished with standard serum-containing medium 
changed on Day 2 and 5 and terminated on Day 7. 
Test substances were added for the last 2 days of 
theculture period. Cortisol was added at a concen- 
tration of 1.0 pg/ml medium. lactate at 2.0 mg/ml 
medium and activator sufficient to generate a 
major response. 
t Lactate was 1.0 mg/ml of medium. All values 
are the mean of triplicate determinations. 
the resistance to glucocorticoid hormone. 
As shown in Table 5, lactate concentra- 
tions of 22 .M/ml (WaK) partially antago- 
nized the steroid effect, while 11.0 pM/ml 
had an equivocal effect. Under our experi- 
mental procedure we seldom develop lac- 
tate concentrations over 9.0 pM/ml, even in 
highly activated cultures, suggesting that 
lactate accumulation is probably not the 
major explanation for steroid resistance 
seen in this in vitro system. 
DISCUSSION 
These data show that rheumatoid synovi- 
a1 cells frequently exhibit increased utiliza- 
tion of glucose, increased formation of lac- 
tate and increased production of hyaluron- 
ic acid. These phenomena have been previ- 
ously shown to be the expected response of 
normal synovial cells to exposure to an 
activator substance. The failure of rheuma- 
toid cells to show the same vigorous re- 
sponse to exogenous CTAP that may be 
demonstrated with nonrheumatoid synovi- 
a1 cells also suggested that the rheumatoid 
cells might be different by virtue of an 
increased content of endogenow activator. 
Experimental evidence indicated that the 
concentration of CTAP activity in rheuma- 
toid synovial cells in culture was approx- 
imately four times that found in nonrheu- 
matoid cells, possibly providing an expla- 
nation for their abnormal metabolic activi- 
ty. The chronic activation experiment indi- 
cated that exogenous activator added to 
normal cells on a repetitive basis would 
induce a state of hyperfunction with re- 
spect to hyaluronic acid formation and 
energy metabolism which faded soon after 
the external source of stimulation was re- 
moved. In addition, the measurable con- 
tent of activator in the cells maintained by 
external stimulation remained markedly 
elevated only so long as the external source 
of CTAP was provided. In  view of this 
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finding, i t  seems unlikely that the demon- 
stration of increased amounts of CTAP in 
rheumatoid synovial cells after several 
months in tissue- culture represents re- 
tained activator derived from lymphoid 
cells or polymorphonuclear leukocytes in 
the original donor tissue milieu. It seems 
most reasonable to conclude that the rheu- 
matoid synovial cells have been altered so 
that they form the connective tissue activat- 
ing peptide either in excessive quantities, 
or possessing unusual activity properties. 
Present data indicate that addition of 
exogenous activator (CTAP) to cultures 
renders them hyporesponsive to cortisol 
with respect to suppression of hyaluronate 
formation. Since rheumatoid cultures, 
which are usually hyporesponsive to cor- 
tisol in this regard, have excessive en- 
dogenous activator, it appears likely that 
defective cortisol regulation of HA forma- 
tion is related to the excessive CTAP con- 
tent of rheumatoid synovial cells. Acceler- 
ated utilization of glucose and formation of 
lactate seen in rheumatoid synovial cells in 
vitro may be explained on the same basis. 
Increased synovial activator may also ex- 
plain the increased energy metabolism of 
rheumatoid synovium and the net increase 
in hyaluronate formed by this tissue in 
rheumatoid arthritis. Other abnormal char- 
acteristics of rheumatoid cells in vitro, such 
as inferior growth rate, tendency to form 
low molecular weight hyaluronate, and de- 
fective cortisol regulation of collagen syn- 
thesis are currently being studied to evalu- 
ate their relationship to the elevated 
CTA4P content of rheumatoid synovial 
cells. 
W e  interpret the data showing a constel- 
lation of propagable abnormalities in rheu- 
matoid synovial cells as suggesting that a 
“primary defect” resides in the synovial 
cells themselves. The present data indicate 
that one propagable abnormality, excess 
CTAP, causes some of the others, including 
increased HA formation and increased glu- 
cose metabolism. The term primary defect 
is used here to indicate that rheumatoid 
synovial cells are essentially permanently 
altered in a way that leads to abnormal cell 
function, in contradistinction to the “inno- 
cent bystander” hypothesis which would 
picture the rheumatoid synovial cells as 
basically normal cells reacting to the con- 
tinuing influence of CTAP formed by 
infiltrating leukocytes. 
The mechanism by which such a primary 
defect might arise in synovial cells is not 
elucidated by the present study. Cellular 
alteration by physical, chemical, immune 
or infectious modalities would be among 
the many possibilities to be considered. 
Reports of possible differences- between 
nonrheumatoid and rheumatoid synovial 
cultures with respect to viral susceptibility 
are of interest in the light of the present 
work. In an extensive study, Ford and Oh 
found no spontaneous degeneration of rheu- 
matoid cultures suggesting latent viral in- 
fection (21). Further, they could not 
demonstrate a significant difference be- 
tween rheumatoid and nonrheumatoid cul- 
tures with respect to susceptibility to New- 
castle disease virus (NDV), nor did they 
find evidence of virus-inactivating or virus- 
interfering activity in fluid from rheuma- 
toid cultures. On the other hand, Smith 
and Hamerman reported preliminary stud- 
ies (22) to ‘the effect that about 85% of 
nonrheumatoid cells were susceptible to 
NDV, while 30 to 60% of rheumatoid cells 
were susceptible, a difference which they 
felt was significant (23). More recently, 
Grayzel has reported that nonrheumatoid 
cells were killed by rubella virus (strain 
F-8) while rheumatoid strains were resis- 
tant (24). Rheumatoid cell resistance to 
rubella was not believed to be mediated by 
interferon. Interpretation of these data is 
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difficult, for one may argue: a) that viral 
resistance reflects a latent or defective virus 
within rheumatoid cells which in turn in- 
duces the spectrum of metabolic abnormal- 
ities which we have identified, or b) that 
activator-induced metabolic abnormalities 
of the  rheumatoid cell cause it to behave 
differently towards viral agents than do 
normal synovial cells. In support of the 
first position i t  is important to recall the 
possibly analogous situation where chicken 
fibroblasts infected with Rous sarcoma vi- 
rus show- accelerated acid mucopolysac- 
charide synthesis and an increase in hy- 
aluronic acid synthetase (25,26). On the 
other hand, i t  would not be surprising i f  
the relatively major physiological differ- 
ences (eg, growth rate, HA and glucose 
metabolism) between normal and rheuma- 
toid cells lead to different viral susceptibili- 
ty, especially in view of evidence that even 
passage status and rate of cell replication 
have a major effect on cell-virus-relation- 
ships (27). 
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